AR064232A1 - Uso de complejos metalicos que contienen perfluoroalquilo como medio de contraste para el diagnostico de emfermedad de alzheimer - Google Patents

Uso de complejos metalicos que contienen perfluoroalquilo como medio de contraste para el diagnostico de emfermedad de alzheimer

Info

Publication number
AR064232A1
AR064232A1 ARP070102000A ARP070102000A AR064232A1 AR 064232 A1 AR064232 A1 AR 064232A1 AR P070102000 A ARP070102000 A AR P070102000A AR P070102000 A ARP070102000 A AR P070102000A AR 064232 A1 AR064232 A1 AR 064232A1
Authority
AR
Argentina
Prior art keywords
complexes containing
perfluoroalquilo
alzheimer
diagnosis
disease
Prior art date
Application number
ARP070102000A
Other languages
English (en)
Inventor
Hanns-Joachim Weinmann
Bernd Misselwitz
Joeerg Meding
Original Assignee
Bayer Schering Pharma Ag
Epix Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag, Epix Pharm Inc filed Critical Bayer Schering Pharma Ag
Publication of AR064232A1 publication Critical patent/AR064232A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Uso de complejos metálicos que contienen al menos un radical alquilo perfluorado y al menos un radical agente quelante y al menos un equivalente de ion metálico que los numeros atomicos 21-29, 31-33, 37-39, 42-44, 49 o 47-83, así como sus sales para la produccion de un agente diagnostico para visualizar placas con contenido de amiloides.
ARP070102000A 2006-05-09 2007-05-09 Uso de complejos metalicos que contienen perfluoroalquilo como medio de contraste para el diagnostico de emfermedad de alzheimer AR064232A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006021495A DE102006021495A1 (de) 2006-05-09 2006-05-09 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit

Publications (1)

Publication Number Publication Date
AR064232A1 true AR064232A1 (es) 2009-03-25

Family

ID=38579874

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102000A AR064232A1 (es) 2006-05-09 2007-05-09 Uso de complejos metalicos que contienen perfluoroalquilo como medio de contraste para el diagnostico de emfermedad de alzheimer

Country Status (8)

Country Link
US (1) US20070269384A1 (es)
AR (1) AR064232A1 (es)
DE (1) DE102006021495A1 (es)
DO (1) DOP2007000091A (es)
PE (1) PE20081570A1 (es)
TW (1) TW200810782A (es)
UY (1) UY30332A1 (es)
WO (1) WO2007128567A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
RU2755181C2 (ru) 2016-11-28 2021-09-14 Байер Фарма Акциенгезельшафт Новые хелатные соединения гадолиния с высокой релаксивностью для применения в магнитно-резонансной визуализации
MX2021006024A (es) 2018-11-23 2021-07-06 Bayer Ag Formulacion de medios de contraste y proceso para prepararlos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
US6676928B2 (en) * 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
US6818203B2 (en) * 2000-08-11 2004-11-16 Schering Aktiengesellschaft Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses
DE10066210B4 (de) * 2000-08-11 2008-02-28 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
DE10231799B4 (de) * 2002-07-10 2006-10-05 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
GB0223249D0 (en) * 2002-10-08 2002-11-13 Amersham Plc Improved imaging agents
AU2004206956A1 (en) * 2003-01-22 2004-08-05 The General Hospital Corporation Amyloid-binding, metal-chelating agents

Also Published As

Publication number Publication date
DE102006021495A1 (de) 2007-11-15
TW200810782A (en) 2008-03-01
US20070269384A1 (en) 2007-11-22
PE20081570A1 (es) 2009-01-04
WO2007128567A1 (de) 2007-11-15
UY30332A1 (es) 2008-01-02
DOP2007000091A (es) 2008-01-31

Similar Documents

Publication Publication Date Title
AR047526A1 (es) Halogenoalquilcarboxamidas
AR053334A1 (es) Pirazolilcarboxanilidas
CR20120264A (es) Compuestos
CO6351754A2 (es) Agentes de contraste que comprenden compuestos fenilo yodados
CR10157A (es) Compuestos químicos
UY30112A1 (es) Nuevos benzotiazoles sustitidos por heteroarilo
UY29742A1 (es) Procedimiento para la preparación de betamimeticos
CY1112722T1 (el) Μυκητοκτονες συνθεσεις
GT201200161A (es) Una forma amorfa y una cristalina de hemitartrato genz 112638 como inhibidor de glucosilceramida sintasa
BRPI0617151B8 (pt) composto, multímero, composto vetorizado, complexo do referido composto, bem como composições farmacêutica, farmacêutica lipídica e de diagnóstico para imagiologia por ressonância magnética e processo para a preparação de um complexo metálico
CL2011002287A1 (es) Compuestos derivados de 8-fenoxi-1,1-dioxido-2,3,4,5-tetrahidro-1,2,5-benzotiadiazepina, moduladores de receptores ampa y nmda; composicion farmaceutica; procedimiento de prepapacion; y su uso para tratar enfermedades neurodegenerativas progresivas, alzheimer, parkinson, corea de huntington, entre otras; compuesto intermediario.
NO20091428L (no) Forbindelser og metoder for 18F-merkede midler
ES2531190T3 (es) Método para producir un compuesto de 4-oxoquinolina
CU20090058A7 (es) Compuestos de pirazolina y su uso y composiciones farmacéuticas
DOP2006000166A (es) Complejos metálicos con contenido de perfluroalquilo, procedimientos para su preparación, así como su uso
CR10842A (es) Derivados de acetileno y su uso para la union a placas amiloides y su diagnostico por imagenes
ECSP11010816A (es) Nuevos Compuestos
AR064232A1 (es) Uso de complejos metalicos que contienen perfluoroalquilo como medio de contraste para el diagnostico de emfermedad de alzheimer
WO2008125422A3 (fr) Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer
BRPI0801188A2 (pt) espaÇador de cimento àsseo de polimetacrilato de metila
CR9939A (es) Uso de piraclostrobina como asegurador para triticonazol para combatir hongos nocivos
CR9645A (es) Complejos con contenido de perfluoroalquilo, procedimientos para su preparacion asi como su uso
BRPI0520092A2 (pt) derivado de feniloxianilina marcado com halogênio radioativo, e, agente de diagnósitico de doença
CO6400226A2 (es) Micrólido anti-inflamatorio
CL2011000520A1 (es) Compuestos derivados de piperazina; uso para preparar un medicamento util para tratar la enfermedad de alzheimaer, un trastorno neurodegenerativo y amiloidosis; metodo de preparacion de compuestos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure